Logo image of SBS.DE

STRATEC SE (SBS.DE) Stock Fundamental Analysis

Europe - FRA:SBS - DE000STRA555 - Common Stock

20.05 EUR
-0.25 (-1.23%)
Last: 11/19/2025, 9:16:07 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SBS. SBS was compared to 60 industry peers in the Health Care Equipment & Supplies industry. SBS has only an average score on both its financial health and profitability. SBS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SBS had positive earnings in the past year.
In the past year SBS had a positive cash flow from operations.
Each year in the past 5 years SBS has been profitable.
Each year in the past 5 years SBS had a positive operating cash flow.
SBS.DE Yearly Net Income VS EBIT VS OCF VS FCFSBS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

SBS's Return On Assets of 3.72% is in line compared to the rest of the industry. SBS outperforms 51.67% of its industry peers.
SBS's Return On Equity of 6.67% is in line compared to the rest of the industry. SBS outperforms 53.33% of its industry peers.
SBS has a Return On Invested Capital (5.32%) which is comparable to the rest of the industry.
SBS had an Average Return On Invested Capital over the past 3 years of 6.93%. This is below the industry average of 8.99%.
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROIC 5.32%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
SBS.DE Yearly ROA, ROE, ROICSBS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 6.22%, SBS is in line with its industry, outperforming 51.67% of the companies in the same industry.
In the last couple of years the Profit Margin of SBS has declined.
SBS's Operating Margin of 10.94% is in line compared to the rest of the industry. SBS outperforms 53.33% of its industry peers.
SBS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 29.65%, SBS is doing worse than 85.00% of the companies in the same industry.
SBS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
SBS.DE Yearly Profit, Operating, Gross MarginsSBS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SBS is still creating some value.
The number of shares outstanding for SBS remains at a similar level compared to 1 year ago.
The number of shares outstanding for SBS has been increased compared to 5 years ago.
The debt/assets ratio for SBS has been reduced compared to a year ago.
SBS.DE Yearly Shares OutstandingSBS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SBS.DE Yearly Total Debt VS Total AssetsSBS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SBS has an Altman-Z score of 2.66. This is not the best score and indicates that SBS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.66, SBS is in line with its industry, outperforming 53.33% of the companies in the same industry.
SBS has a debt to FCF ratio of 41.27. This is a negative value and a sign of low solvency as SBS would need 41.27 years to pay back of all of its debts.
SBS's Debt to FCF ratio of 41.27 is on the low side compared to the rest of the industry. SBS is outperformed by 60.00% of its industry peers.
SBS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
SBS has a worse Debt to Equity ratio (0.49) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Altman-Z 2.66
ROIC/WACC0.81
WACC6.56%
SBS.DE Yearly LT Debt VS Equity VS FCFSBS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 4.19 indicates that SBS has no problem at all paying its short term obligations.
SBS has a better Current ratio (4.19) than 93.33% of its industry peers.
A Quick Ratio of 1.65 indicates that SBS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.65, SBS is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.19
Quick Ratio 1.65
SBS.DE Yearly Current Assets VS Current LiabilitesSBS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

SBS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.26%.
Measured over the past 5 years, SBS shows a small growth in Earnings Per Share. The EPS has been growing by 2.20% on average per year.
SBS shows a decrease in Revenue. In the last year, the revenue decreased by -4.73%.
SBS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.76% yearly.
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%

3.2 Future

Based on estimates for the next years, SBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.42% on average per year.
The Revenue is expected to grow by 7.45% on average over the next years.
EPS Next Y-8.24%
EPS Next 2Y12.38%
EPS Next 3Y13.9%
EPS Next 5Y14.42%
Revenue Next Year2.19%
Revenue Next 2Y4.53%
Revenue Next 3Y5.38%
Revenue Next 5Y7.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SBS.DE Yearly Revenue VS EstimatesSBS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
SBS.DE Yearly EPS VS EstimatesSBS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

SBS is valuated correctly with a Price/Earnings ratio of 15.19.
Based on the Price/Earnings ratio, SBS is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
SBS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.51.
SBS is valuated reasonably with a Price/Forward Earnings ratio of 10.03.
Based on the Price/Forward Earnings ratio, SBS is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
SBS is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.19
Fwd PE 10.03
SBS.DE Price Earnings VS Forward Price EarningsSBS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SBS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SBS is cheaper than 88.33% of the companies in the same industry.
SBS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 76.09
EV/EBITDA 7.52
SBS.DE Per share dataSBS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

SBS's earnings are expected to grow with 13.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)6.92
EPS Next 2Y12.38%
EPS Next 3Y13.9%

4

5. Dividend

5.1 Amount

SBS has a Yearly Dividend Yield of 2.82%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of SBS has falen by -21.77%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
SBS's Dividend Yield is rather good when compared to the industry average which is at 2.11. SBS pays more dividend than 90.00% of the companies in the same industry.
SBS's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.82%

5.2 History

The dividend of SBS decreases each year by -7.63%.
Dividend Growth(5Y)-7.63%
Div Incr Years0
Div Non Decr Years5
SBS.DE Yearly Dividends per shareSBS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

45.53% of the earnings are spent on dividend by SBS. This is a bit on the high side, but may be sustainable.
DP45.53%
EPS Next 2Y12.38%
EPS Next 3Y13.9%
SBS.DE Yearly Income VS Free CF VS DividendSBS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
SBS.DE Dividend Payout.SBS.DE Dividend Payout, showing the Payout Ratio.SBS.DE Dividend Payout.PayoutRetained Earnings

STRATEC SE

FRA:SBS (11/19/2025, 9:16:07 AM)

20.05

-0.25 (-1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2025-11-07
Earnings (Next)N/A N/A
Inst Owners35.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap243.81M
Revenue(TTM)257.62M
Net Income(TTM)16.02M
Analysts78.46
Price Target37.16 (85.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.82%
Yearly Dividend0.55
Dividend Growth(5Y)-7.63%
DP45.53%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.91%
PT rev (3m)-5.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.41%
EPS NY rev (3m)-18.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-2.91%
Valuation
Industry RankSector Rank
PE 15.19
Fwd PE 10.03
P/S 0.95
P/FCF 76.09
P/OCF 11.16
P/B 1.02
P/tB 1.93
EV/EBITDA 7.52
EPS(TTM)1.32
EY6.58%
EPS(NY)2
Fwd EY9.97%
FCF(TTM)0.26
FCFY1.31%
OCF(TTM)1.8
OCFY8.96%
SpS21.19
BVpS19.74
TBVpS10.36
PEG (NY)N/A
PEG (5Y)6.92
Graham Number24.22
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROCE 7.38%
ROIC 5.32%
ROICexc 5.68%
ROICexgc 8.34%
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
FCFM 1.24%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
ROICexc(3y)7.69%
ROICexc(5y)10.12%
ROICexgc(3y)11.48%
ROICexgc(5y)16.01%
ROCE(3y)9.61%
ROCE(5y)11.28%
ROICexgc growth 3Y-26.1%
ROICexgc growth 5Y2.82%
ROICexc growth 3Y-25.31%
ROICexc growth 5Y3.93%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Debt/EBITDA 2.49
Cap/Depr 99.05%
Cap/Sales 7.24%
Interest Coverage 5.44
Cash Conversion 46.48%
Profit Quality 20%
Current Ratio 4.19
Quick Ratio 1.65
Altman-Z 2.66
F-Score7
WACC6.56%
ROIC/WACC0.81
Cap/Depr(3y)101.4%
Cap/Depr(5y)105.66%
Cap/Sales(3y)6.8%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
EPS Next Y-8.24%
EPS Next 2Y12.38%
EPS Next 3Y13.9%
EPS Next 5Y14.42%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%
Revenue Next Year2.19%
Revenue Next 2Y4.53%
Revenue Next 3Y5.38%
Revenue Next 5Y7.45%
EBIT growth 1Y-3.3%
EBIT growth 3Y-17.64%
EBIT growth 5Y9.13%
EBIT Next Year60.68%
EBIT Next 3Y28.29%
EBIT Next 5Y15.58%
FCF growth 1Y114.46%
FCF growth 3Y-10.96%
FCF growth 5YN/A
OCF growth 1Y1784.43%
OCF growth 3Y-8.44%
OCF growth 5Y18.03%

STRATEC SE / SBS.DE FAQ

Can you provide the ChartMill fundamental rating for STRATEC SE?

ChartMill assigns a fundamental rating of 4 / 10 to SBS.DE.


What is the valuation status of STRATEC SE (SBS.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to STRATEC SE (SBS.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for STRATEC SE?

STRATEC SE (SBS.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of STRATEC SE (SBS.DE) stock?

The Price/Earnings (PE) ratio for STRATEC SE (SBS.DE) is 15.19 and the Price/Book (PB) ratio is 1.02.


What is the expected EPS growth for STRATEC SE (SBS.DE) stock?

The Earnings per Share (EPS) of STRATEC SE (SBS.DE) is expected to decline by -8.24% in the next year.